Clinical Trials Browser

Interventional × Patients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication × Clear all

NCT06221657 2024-01-24

Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral Treatment

Phase 4 Not yet recruiting

Patients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication